Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuji Murakami

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Cancer Chemotherapy and Pharmacology|November 9, 2017
Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancerShuji Murakami, Haruhiro Saito, Tetsuro Kondo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 9, 2014
Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lungYasuhiro Tsutani, Shuji Murakami, Yoshihiro Miyata, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2013
Periaortitis associated with anti-neutrophil cytoplasmic antibodies induced by bevacizumab combination therapyShuji Murakami, Haruhiro Saito, Miki Ohe, et al.
Journal of Experimental Therapeutics & Oncology|May 5, 2017
Nedaplatin and irinotecan with concurrent thoracic radiotherapy followed by docetaxel consolidation in patients with locally advanced non-small cell lung cancerFumihiro Oshita, Shuji Murakami, Tetsuro Kondo, et al.
Clinical and Vaccine Immunology : CVI|March 21, 2008
Diagnosis of tuberculous meningitis due to detection of ESAT-6-specific gamma interferon production in cerebrospinal fluid enzyme-linked immunospot assayShuji Murakami, Mitsuhiro Takeno, Hideaki Oka, et al.
Cancers|July 15, 2026
Comparison of Amplicon-Based Next-Generation Sequencing Testing and Immunohistochemical Staining in Detecting <i>Anaplastic Lymphoma Kinase</i> Fusion Genes in Non-Small-Cell Lung Cancer: A Large Single-Centre Cohort StudyYuichiro Suzukawa, Yuto Tagawa, Seigo Katakura, et al.
Anticancer Research|April 12, 2012
Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lungYoshiyuki Kenmotsu, Fumihiro Oshita, Makiko Sugiura, et al.
General Thoracic and Cardiovascular Surgery|June 9, 2017
Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?Hiroyuki Ito, Haruhiko Nakayama, Shuji Murakami, et al.
Thoracic Cancer|June 2, 2026
Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective StudyShuji Murakami, Yukihiko Hiroshima, Seigo Katakura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 15, 2016
Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Phase III Randomized Controlled Trials Evaluating the First-Line Chemotherapy for Advanced, Locally Advanced, and Recurrent Non-Small Cell Lung CarcinomaKentaro Nakashima, Nobuyuki Horita, Kenjiro Nagai, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|November 9, 2017
Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancerShuji Murakami, Haruhiro Saito, Tetsuro Kondo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 9, 2014
Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lungYasuhiro Tsutani, Shuji Murakami, Yoshihiro Miyata, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2013
Periaortitis associated with anti-neutrophil cytoplasmic antibodies induced by bevacizumab combination therapyShuji Murakami, Haruhiro Saito, Miki Ohe, et al.
Journal of Experimental Therapeutics & Oncology|May 5, 2017
Nedaplatin and irinotecan with concurrent thoracic radiotherapy followed by docetaxel consolidation in patients with locally advanced non-small cell lung cancerFumihiro Oshita, Shuji Murakami, Tetsuro Kondo, et al.
Clinical and Vaccine Immunology : CVI|March 21, 2008
Diagnosis of tuberculous meningitis due to detection of ESAT-6-specific gamma interferon production in cerebrospinal fluid enzyme-linked immunospot assayShuji Murakami, Mitsuhiro Takeno, Hideaki Oka, et al.
Cancers|July 15, 2026
Comparison of Amplicon-Based Next-Generation Sequencing Testing and Immunohistochemical Staining in Detecting <i>Anaplastic Lymphoma Kinase</i> Fusion Genes in Non-Small-Cell Lung Cancer: A Large Single-Centre Cohort StudyYuichiro Suzukawa, Yuto Tagawa, Seigo Katakura, et al.
Anticancer Research|April 12, 2012
Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lungYoshiyuki Kenmotsu, Fumihiro Oshita, Makiko Sugiura, et al.
General Thoracic and Cardiovascular Surgery|June 9, 2017
Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?Hiroyuki Ito, Haruhiko Nakayama, Shuji Murakami, et al.
Thoracic Cancer|June 2, 2026
Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective StudyShuji Murakami, Yukihiko Hiroshima, Seigo Katakura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 15, 2016
Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Phase III Randomized Controlled Trials Evaluating the First-Line Chemotherapy for Advanced, Locally Advanced, and Recurrent Non-Small Cell Lung CarcinomaKentaro Nakashima, Nobuyuki Horita, Kenjiro Nagai, et al.
Pageof 12